0914 ET - Restaurant executives are watching for signs of slower sales as more Americans take GLP-1 weight loss drugs, but Burger King owner Restaurant Brands International thinks it's prepared to meet any demand shift. Weight-loss drug users often seek out protein while using the medications, and Burger King's products are protein rich, CEO Josh Kobza said during an investor event. The chain's Double Cheeseburger is a smaller size with a high meat to bread ratio, making it a potential draw for GLP-1 users, Kobza says. (heather.haddon@wsj.com; @heatherhaddon)
(END) Dow Jones Newswires
December 03, 2025 09:15 ET (14:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.